Gates Foundation grants Pirbright Institute £2.1 million to investigate cattle antibody responses to virus-like particles vaccines.
While hay production is expected to show a slight increase, lower beginning stocks mean tighter supplies and higher prices.
Funding will advance commercial production of a new, low-cost vaccine targeted at FMD endemic regions.